OR4A14P

Across TCGA pan-cancer cohorts, OR4A14P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR4A14P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR4A14P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR4A14P expression acts as an unfavorable survival marker, although some lineages such as ESCA and SKCM show a favorable association.

MESO, THCA, and STAD are the cancer types where OR4A14P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.052	0.567	<.001	108	view →
THCA	OS	Tertile	All	0.711	0.965	<.001	81	view →
STAD	DFS	Tertile	II,III,IV	0.173	0.440	.001	75	view →
DLBC	DFS	Tertile	All	0.426	0.841	.018	63	view →
KIRP	OS	Tertile	All	0.758	0.956	<.001	24	view →
BLCA	OS	Tertile	IV	0.052	0.575	<.001	18	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
GBM	OS	Tertile	All	0.101	0.413	.035	9	view →
SARC	DFS	Tertile	All	0.081	0.632	<.001	9	view →
ESCA	OS	Tertile	II,III,IV	0.657	0.382	.034	8	view →
SKCM	OS	Tertile	III,IV	0.884	0.359	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

OR4A14P–MESO (OS)

Open the MESO breakdown →